Evidence map›Paper›PMID 39998272›Full record

ArticleSmall methods2026

Breaking the Low Concentration Barrier of Single-Molecule Fluorescence Quantification to the Sub-Picomolar Range.

Malavika Kayyil Veedu, Jérôme Wenger

Abstract read
In one paragraph

Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Malavika Kayyil VeeduAix Marseille Univ, CNRS, Centrale Med, Institut Fresnel, AMUTech, Marseille, 13013, France.
Jérôme WengerAix Marseille Univ, CNRS, Centrale Med, Institut Fresnel, AMUTech, Marseille, 13013, France.ORCID https://orcid.org/0000-0002-2145-5341

Funding

HORIZON EUROPE Marie Sklodowska-Curie Actions 101072818
6 · The paper itself

Abstract

Single-molecule fluorescence techniques provide exceptional sensitivity to probe biomolecular interactions. However, their application to accurately quantify analytes at the picomolar concentrations relevant for biosensing remains challenged by a severe degradation in the signal-to-background ratio. This so-called "low concentration barrier" is a major factor hindering the broad application of single-molecule fluorescence to biosensing. Here, the low concentration limit is broken into while keeping intact the confocal microscope architecture and without requiring complex microfluidics or preconcentration stages. Using fluorescence lifetime correlation spectroscopy (FLCS) and adding a diaphragm to the laser excitation beam, a limit of quantitation (LOQ) down to 0.1 pM is achieved, significantly below the state-of-the-art. The physical parameters setting the LOQ and introduce a broadly applicable figure of merit (FoM) is identified that determines the LOQ and allows for a clear comparison between experimental configurations. The approach preserves the ability to monitor dynamic interactions, and diffusion times, and distinguish species in complex mixtures. This feature is illustrated by measuring the biotin-streptavidin association rate constant which is highly challenging to assess quantitatively due to the strong affinity of the biotin-streptavidin interaction. These findings push the boundaries of single-molecule fluorescence detection for biosensing applications at sub-picomolar concentrations with high accuracy and simplified systems.

Indexed as

Biosensing TechniquesSingle Molecule ImagingBiotinFluorescenceLimit of DetectionMicroscopy, ConfocalSpectrometry, FluorescenceStreptavidinBiotinStreptavidinbiomolecular association dynamicsbiotin‐streptavidin interactionconfocal microscopyfluorescence lifetime correlation spectroscopy FLCSfluorescence sensinglimit of quantitation

Identifiers

PMID39998272
PMCPMC12825359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.